Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Conditions

Breast Neoplasms 2232 Neoplasms 2038 Lung Neoplasms 1096 Colorectal Neoplasms 1036 Prostatic Neoplasms 894 Carcinoma, Non-Small-Cell Lung 752 Carcinoma, Hepatocellular 673 Stomach Neoplasms 607 Pancreatic Neoplasms 602 Head and Neck Neoplasms 434 Ovarian Neoplasms 430 Colonic Neoplasms 423 Rectal Neoplasms 406 Uterine Cervical Neoplasms 403 Esophageal Neoplasms 346 Brain Neoplasms 329 Neoplasm Metastasis 324 Melanoma 306 Multiple Myeloma 304 Precursor Cell Lymphoblastic Leukemia-Lymphoma 293 Urinary Bladder Neoplasms 290 Leukemia, Myeloid, Acute 278 Lymphoma 268 Liver Neoplasms 253 Endometrial Neoplasms 253 Hematologic Neoplasms 252 Disease 244 Recurrence 225 Glioma 218 Carcinoma, Renal Cell 207

Interventions

anlotinib 1 Angiogenesis Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Observational × Stereotactic Body Radiation Therapy × Clear all

NCT04912128 2021-06-03

AnloSBRT

Peking University Third Hospital

Stereotactic Body Radiation Therapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡